David S. Pearson

David S. Pearson

Auto-generated profile, based on publicly available information

David S. Pearson

Department of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Eukaryotic Cell
Verified
Journal Article
Open access
PDF file
EMEstelle Gewiss Mogensen
Estelle Gewiss Mogensen
GJGuilhem Janbon
Guilhem Janbon
JCJames Chaloupka
James Chaloupka
CSClemens Steegborn
Clemens Steegborn
MFMan Shun Fu
Man Shun Fu
FMFritz A. MühLschlegel
Fritz A. MühLschlegel
Cryptococcus neoformans , a fungal pathogen of humans, causes fatal meningitis in immunocompromised patients. Its virulence is mainly determined by the elaboration of a polysaccharide capsule surrounding its cell wall. During its life, C. neoformans is confronted with and responds to dramatic variations in CO 2 concentrations; one important morphological change triggered by the shift from its natural habitat (0.033% CO 2 ) to infected hosts (5% CO 2 ) is the induction of capsule biosynthesis. In cells, CO 2 is hydrated to bicarbonate in a spontaneous reaction that is accelerated by carbonic anhydrases. Here we show that C. neoformans contains two β-class carbonic anhydrases, Can1 and Can2. We further demonstrate that CAN2 , but not CAN1 , is abundantly expressed and essential for the growth of C. neoformans in its natural environment, where CO 2 concentrations are limiting. Structural studies reveal that Can2 forms a homodimer in solution. Our data reveal Can2 to be the main carbonic anhydrase and suggest a physiological role for bicarbonate during C. neoformans growth. Bicarbonate directly activates the C. neoformans Cac1 adenylyl cyclase required for capsule synthesis. We show that this specific activation is optimal at physiological pH.

12 March 2005 in Biochemistry
Verified
Journal Article
Closed access
TMTim B. McAnaney
Tim B. McAnaney
WZWei Zeng
Wei Zeng
CDCamille F. E. Doe
Camille F. E. Doe
NBNina Bhanji
Nina Bhanji
SWStuart Wakelin
Stuart Wakelin
CBClive R. Bagshaw
Clive R. Bagshaw

28 September 2001 in Biochemistry
Verified
Journal Article
Closed access
AMAndrás Málnási-Csizmadia
András Málnási-Csizmadia
DPDavid S. Pearson
David S. Pearson
MKMihály Kovács
Mihály Kovács
RWRobert J. Woolley
Robert J. Woolley
MGMichael A. Geeves
Michael A. Geeves
CBClive R. Bagshaw
Clive R. Bagshaw

1 June 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AMAndraés Maélnaési-Csizmadia
Andraés Maélnaési-Csizmadia
JTJudit Toéth
Judit Toéth
DPDavid S. Pearson
David S. Pearson
Csaba HetényiCsaba Hetényi
Csaba Hetényi
LNLaészloé Nyitray
Laészloé Nyitray
MKMihaély Kovaécs
Mihaély Kovaécs
After ATP binding the myosin head undergoes a large structural rearrangement called the recovery stroke. This transition brings catalytic residues into place to enable ATP hydrolysis, and at the same time it causes a swing of the myosin lever arm into a primed state, which is a prerequisite for the power stroke. By introducing point mutations into a subdomain interface at the base of the myosin lever arm at positions Lys84 and Arg704, we caused modulatory changes in the equilibrium constant of the recovery stroke, which we could accurately resolve using the fluorescence signal of single tryptophan Dictyostelium myosin II constructs. Our results shed light on a novel role of the recovery stroke: fine-tuning of this reversible equilibrium influences the functional properties of myosin through controlling the effective rates of ATP hydrolysis and phosphate release.

10 January 2007 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
BKBálint Kintses
Bálint Kintses
MGMáté Gyimesi
Máté Gyimesi
DPDavid S Pearson
David S Pearson
MGMichael A Geeves
Michael A Geeves
WZWei Zeng
Wei Zeng
AMAndrás Málnási‐Csizmadia
András Málnási‐Csizmadia

1 September 2002 in Biochemical Journal
Verified
Journal Article
Closed access
DPDavid S. Pearson
David S. Pearson
GHGeorg Holtermann
Georg Holtermann
PEPatricia Ellison
Patricia Ellison
CCChristine Cremo
Christine Cremo
MGMichael A. Geeves
Michael A. Geeves
Reactions involving proteins frequently involve large changes in volume, which allows the equilibrium position to be perturbed by changes in pressure. Rapid changes in pressure can thus be used to initiate relaxation in pressure; however, this approach is seldom used, because it requires specialized equipment. We have built a microvolume (50μl) pressure-jump apparatus, powered by a piezoelectric actuator, based on the original design of Clegg and Maxfield [(1976) Rev. Sci. Instrum. 47, 1383–1393]. This equipment can apply pressure changes of ±20MPa (maximally) in time periods as short as 80μs and follow the resulting change in fluorescence signals. The system is relatively simple to use with fast (approx. 1min) exchange of samples. In the present study, we show that this system can perturb the binding of 2′(3′)-O-(N-methylanthraniloyl)-ADP to myosin subfragment-1(S1) from skeletal and smooth muscles. The kinetic data are consistent with previous work, and in addition show that, although 2′(3′)-O-(N-methylanthraniloyl)-ADP binds with a similar affinity to both proteins, the increase in molar volume for the skeletal-muscle S1 binding to ADP is half of that for the smooth-muscle protein. This high-volume change for smooth-muscle S1 may be related to the ability of ADP to induce a 23° tilt in the tail of S1 bound to actin.